期刊文献+

RamR突变协同靶位基因突变对沙门氏菌耐药性影响的研究

下载PDF
导出
摘要 从实验室保存的沙门菌中筛选出33株对环丙沙星呈现不同敏感程度的分离株,采用PCR方法检测喹诺酮类作用靶位基因突变和外排泵调控基因ramA的负调控蛋白编码基因ramR的突变。结果表明,33株沙门菌中,凡是高水平耐药菌和环丙沙星耐药菌株都发生GyrA-ParC的多位点突变,突变主在gyrA和parC基因的QRDR,~PGyrA发生83和87位的双突变(S83F/D87G,8株;S83F/D87N,5株;S83L/D87N,1株),ParC发生57和80位的双突变(T57S/S80R)。15株对环丙沙星敏感性下降的菌株中,有5株在gyrA83位发生单位点突变,有5株在87位发生氨基酸的取代(3株D87Y,2株D87N),其余4株在4个靶位基因的QRDR都没有发生任何突变。对33株沙门菌ramR扩增测序后发现,15株菌的ramR发生突变,共有4种突变类型,M83T(n=6),A37S(n=3),T18P(n=3)和氨基酸的缺失(n=3)。剩下的18株,无论对环丙沙星敏感/敏感性降低还是耐药,ramR没有检测到任何突变。
出处 《兽医导刊》 2015年第24期51-52,175,共3页 Veterinary Orientation
  • 相关文献

参考文献14

  • 1AIVAREZ-FEMANDEZ, E., et al., Prevalence and antimicrobial resistance of Salmonella serotypes isolated from poultry in Spain :comparison between 1993 and 2006[J].Int J Food Microbiol, 2012, 153 (3) : 281-287.
  • 2SHIN, H., et al., Complete genome sequence of Salmonella enterica serovar typhimurium bacteriophage SPN1S[J].J Virol, 2012, 86 (2) : 1284-1285.
  • 3HOPKINS, K.L., R.H. DAVIES, and E.J. Threlfall, Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments[J].Int J Antimicrob Agents, 2005, 25 ( 5 ) : 358-373.
  • 4BAUCHERON, S., E. ChASLUS-DANCLA, and A. C1OECKAERT, Role of TolC and parC mutation in high- level fluoroquinolone resistance in Salmonella enterica serotype Typhimufium DT204[J].J Antimicrob Chemother, 2004, 53 ( 4 ) : 657-659.
  • 5GIRAUD, E., et al., Evidence for Active Efflux as the Primary Mechanism of Resistance to Ciprofloxacin in Salmonella enterica Serovar Typhimurium[J].Antimicrobial Agents and Chemotherapy, 2000, 44 (5) : 1223-1228.
  • 6ASAKO, H., et al., Organic solvent tolerance and antibiotic resistance increased by overexpression of marA in Eseberichia coli[J]. Appl Environ Microbiol, 1997, 63 ( 4 ) : 1428-1433.
  • 7NIKAIDO, H. and J.M. PAGES, Broad-specificity effiux pumps and their role in multidrug resistance of Gram-negative bacteria[J]. FEMS MierobiolRev, 2012, 36 (2) : 340-363.
  • 8ABOUZEED, Y.M., S. BAUCHERON, and A. CLOECKAERT1, ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium[J].Antimicrob Agents Chemother, 2008, 52 (7) : 2428-2434.
  • 9NIKAIDO, E., A. YAMAGUCHIi, and K. NISHION, AcrAB multidrug efflux pump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals[J].J Biol Chem, 2008, 283 (35) : 24245-24253.
  • 10ZhENG, J., S. CUI, and J. MENG, Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium[J].J Antimicrob Chemother, 2009, 63 (1) : 95-102.

二级参考文献14

  • 1黄长武,李兴禄,黄坤容,陈维贤,邱君凤,聂红.大肠埃希菌耐药性分析[J].中国抗感染化疗杂志,2004,4(6):356-358. 被引量:12
  • 2Karlowsky JA,Hoban DJ,Decorby MR.Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant:results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance Study[J].Antimicrob Agents Chemother,2006,50(6):2251-2254.
  • 3Cattoir V,Lesprit P,Lascols C,et al.In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid[J].J Antimicrob Chemother,2006,58(5):1054-1057.
  • 4Petersen A,Christensen JP,Kuhnert P.Vertical transmission of a fluoroquinolone-resistant Escherichia coli within an integrated broiler operation[J].Vet Microbiol,2006,116(1-3):120-128.
  • 5Chenia HY, Pillay B, Pillay D. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens [ J ]. J Antimicrob Chemother, 2006, 58(6) :1274-1278.
  • 6Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection [ J ]. J Antimicrob Chemother, 2003, 51 (5) :1109-1117.
  • 7Shenz Y, Ruiz J, Zarazaga M, et al. Effect of the efflux pump inhibitor Phe-Arg-beta-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin [ J ]. J Antimicrob Chemother, 2004, 53 ( 3 ) : 544-545.
  • 8Park CH, Robicsek A ,Jacoby GA, et al. Prevalence in the United States of aac (6')-Ib-cr encoding a ciprofloxacin-modifying enzyme [ J ]. Antimicrob Agents Chemother, 2006, 50 ( 11 ) : 3953-3955.
  • 9Robicsek A, Sahm DF, Strahilevitz J, et al. Broader distribution of plasmid-mediated quinolone resistance in the United States [ J ]. Antimicrob Agents Chemother, 2005,49(7) :3001-3003.
  • 10Morgan-Linnell SK, Bethel Boyd L, Steffen D, et al. Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates [ J ]. Antimicrob Agents Chemother,2009, 53(1 ) :235-241.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部